Summary by Moomoo AI
Elaine O'Hara, EVP, Chief Strategy Officer at Novavax, Inc. [NVAX], was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. This information is critical for investors to understand the potential impact on their investment in Novavax.